• Thu, December 31, 2020
• Mon, January 4, 2021
• Mon, December 28, 2020
• Tue, December 29, 2020
• Wed, December 30, 2020
John Newman Maintained (AGIO) at Strong Buy with Decreased Target to $57 on, Dec 28th, 2020
John Newman of Canaccord Genuity, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Strong Buy with Decreased Target from $70 to $57 on, Dec 28th, 2020.
John has made no other calls on AGIO in the last 4 months.
There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 0 agree with John's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with John
- Andrew Berens of "SVB Leerink" Maintained at Buy with Decreased Target to $61 on, Wednesday, December 9th, 2020
- Peter Lawson of "Barclays" Upgraded from Hold to Buy and Held Target at $46 on, Thursday, October 22nd, 2020
